Hospital Acquired Infections Diagnostics Market Size, Share, Trends, Growth Outlook

Hospital Acquired Infections Diagnostics Market is estimated to increase at a growth rate of 7.1% CAGR over the forecast period from 2024 to 2030.

The Hospital Acquired Infections Diagnostics Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Test (Molecular, Conventional), By Infection (UTI, Pneumonia, Surgical site infection, Blood stream infections, Others), By Product (Consumables, Instruments), By Type (Blood tests, Urinalysis).

An Introduction to Hospital Acquired Infections Diagnostics Market in 2024

The Hospital Acquired Infections Diagnostics market in 2024 is witnessing robust growth driven by the increasing prevalence of healthcare-associated infections (HAIs), rising awareness about infection control practices, and advancements in diagnostic technologies. HAIs represent a significant burden on healthcare systems worldwide, contributing to patient morbidity, mortality, and healthcare costs. The market offers a diverse range of diagnostic tests and surveillance solutions to identify and monitor HAIs, including bloodstream infections, urinary tract infections, surgical site infections, and respiratory infections. With factors such as antibiotic resistance, regulatory mandates, and quality accreditation requirements driving demand for rapid and accurate diagnostic solutions, hospitals and healthcare facilities are investing in advanced testing platforms, molecular assays, and syndromic testing panels to enhance infection prevention and control practices, reduce transmission rates, and improve patient outcomes. Moreover, with the emergence of novel pathogens and infectious disease threats, the hospital-acquired infections diagnostics market is poised for continued innovation and investment in research and development efforts aimed at addressing evolving healthcare challenges and improving patient safety.

Hospital Acquired Infections Diagnostics Market Trend: Increasing Focus on Antimicrobial Stewardship

A prominent trend in the hospital-acquired infections (HAIs) diagnostics market is the increasing focus on antimicrobial stewardship programs within healthcare facilities. With the rise of antimicrobial resistance and the growing threat of multidrug-resistant pathogens, healthcare providers are prioritizing strategies to optimize antimicrobial use and combat the spread of resistant infections. Antimicrobial stewardship programs aim to improve the appropriate selection, dosing, and duration of antimicrobial therapy through enhanced diagnostics, surveillance, and interventions. As a result, there is a growing demand for advanced HAI diagnostics that enable rapid identification of pathogens, antimicrobial susceptibility testing, and molecular characterization of resistance mechanisms, supporting targeted antimicrobial therapy and infection control efforts.

Hospital Acquired Infections Diagnostics Market Driver: Regulatory Requirements and Quality Standards

A key driver in the hospital-acquired infections (HAIs) diagnostics market is the implementation of regulatory requirements and quality standards for infection prevention and control. Regulatory agencies and healthcare organizations worldwide have established guidelines, protocols, and performance benchmarks to ensure compliance with infection control measures and reduce the incidence of HAIs. These mandates often necessitate routine surveillance, screening, and testing for common pathogens associated with HAIs, such as bacteria, viruses, and fungi. The emphasis on adherence to regulatory standards drives market demand for HAI diagnostics solutions that enable healthcare facilities to meet accreditation requirements, enhance infection control practices, and improve patient safety outcomes through early detection and management of hospital-acquired infections.

Hospital Acquired Infections Diagnostics Market Opportunity: Development of Multiplex Diagnostic Assays

An opportunity for growth in the hospital-acquired infections (HAIs) diagnostics market lies in the development of multiplex diagnostic assays for comprehensive pathogen detection. Traditional diagnostic methods often involve time-consuming and labor-intensive testing processes for individual pathogens, leading to delays in diagnosis and treatment initiation for patients at risk of HAIs. By investing in research and development of multiplex assays, manufacturers can offer innovative testing solutions that simultaneously detect multiple pathogens and resistance markers associated with HAIs in a single test panel. Multiplex assays enable rapid identification of infectious agents, antimicrobial susceptibility profiling, and characterization of virulence factors, facilitating timely intervention, targeted antimicrobial therapy, and infection control measures. This opportunity aligns with the industry's focus on advancing diagnostic technologies and improving patient outcomes through early and accurate detection of hospital-acquired infections.

Hospital Acquired Infections Diagnostics Market Segmentation

By Test
Molecular
Conventional
By Infection
UTI
Pneumonia
Surgical site infection
Blood stream infections
Others
By Product
Consumables
Instruments
By Type
Blood tests
Urinalysis
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Hospital Acquired Infections Diagnostics Market Companies

Abbott
Becton, Dickinson and Company
BIOMÉRIEUX
Bioscience Inc
F. Hoffmann-La Roche Ltd
Hologic Inc
Meridian Bioscience Inc
QIAGEN
Siemens Healthcare Private Ltd
Thermo Fisher Scientific Inc

 

 

Reasons to Buy the Hospital Acquired Infections Diagnostics Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Hospital Acquired Infections Diagnostics Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Hospital Acquired Infections Diagnostics Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Hospital Acquired Infections Diagnostics Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Hospital Acquired Infections Diagnostics Market Size Outlook, $ Million, 2021 to 2030
3.2 Hospital Acquired Infections Diagnostics Market Outlook by Type, $ Million, 2021 to 2030
3.3 Hospital Acquired Infections Diagnostics Market Outlook by Product, $ Million, 2021 to 2030
3.4 Hospital Acquired Infections Diagnostics Market Outlook by Application, $ Million, 2021 to 2030
3.5 Hospital Acquired Infections Diagnostics Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Hospital Acquired Infections Diagnostics Market Industry
4.2 Key Market Trends in Hospital Acquired Infections Diagnostics Market Industry
4.3 Potential Opportunities in Hospital Acquired Infections Diagnostics Market Industry
4.4 Key Challenges in Hospital Acquired Infections Diagnostics Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Hospital Acquired Infections Diagnostics Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Hospital Acquired Infections Diagnostics Market Outlook By Segments
7.1 Hospital Acquired Infections Diagnostics Market Outlook by Segments
By Test
Molecular
Conventional
By Infection
UTI
Pneumonia
Surgical site infection
Blood stream infections
Others
By Product
Consumables
Instruments
By Type
Blood tests
Urinalysis

8 North America Hospital Acquired Infections Diagnostics Market Analysis And Outlook To 2030
8.1 Introduction to North America Hospital Acquired Infections Diagnostics Markets in 2024
8.2 North America Hospital Acquired Infections Diagnostics Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Hospital Acquired Infections Diagnostics Market size Outlook by Segments, 2021-2030
By Test
Molecular
Conventional
By Infection
UTI
Pneumonia
Surgical site infection
Blood stream infections
Others
By Product
Consumables
Instruments
By Type
Blood tests
Urinalysis

9 Europe Hospital Acquired Infections Diagnostics Market Analysis And Outlook To 2030
9.1 Introduction to Europe Hospital Acquired Infections Diagnostics Markets in 2024
9.2 Europe Hospital Acquired Infections Diagnostics Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Hospital Acquired Infections Diagnostics Market Size Outlook By Segments, 2021-2030
By Test
Molecular
Conventional
By Infection
UTI
Pneumonia
Surgical site infection
Blood stream infections
Others
By Product
Consumables
Instruments
By Type
Blood tests
Urinalysis

10 Asia Pacific Hospital Acquired Infections Diagnostics Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Hospital Acquired Infections Diagnostics Markets in 2024
10.2 Asia Pacific Hospital Acquired Infections Diagnostics Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Hospital Acquired Infections Diagnostics Market size Outlook by Segments, 2021-2030
By Test
Molecular
Conventional
By Infection
UTI
Pneumonia
Surgical site infection
Blood stream infections
Others
By Product
Consumables
Instruments
By Type
Blood tests
Urinalysis

11 South America Hospital Acquired Infections Diagnostics Market Analysis And Outlook To 2030
11.1 Introduction to South America Hospital Acquired Infections Diagnostics Markets in 2024
11.2 South America Hospital Acquired Infections Diagnostics Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Hospital Acquired Infections Diagnostics Market size Outlook by Segments, 2021-2030
By Test
Molecular
Conventional
By Infection
UTI
Pneumonia
Surgical site infection
Blood stream infections
Others
By Product
Consumables
Instruments
By Type
Blood tests
Urinalysis

12 Middle East And Africa Hospital Acquired Infections Diagnostics Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Hospital Acquired Infections Diagnostics Markets in 2024
12.2 Middle East and Africa Hospital Acquired Infections Diagnostics Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Hospital Acquired Infections Diagnostics Market size Outlook by Segments, 2021-2030
By Test
Molecular
Conventional
By Infection
UTI
Pneumonia
Surgical site infection
Blood stream infections
Others
By Product
Consumables
Instruments
By Type
Blood tests
Urinalysis

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott
Becton, Dickinson and Company
BIOMÉRIEUX
Bioscience Inc
F. Hoffmann-La Roche Ltd
Hologic Inc
Meridian Bioscience Inc
QIAGEN
Siemens Healthcare Private Ltd
Thermo Fisher Scientific Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Test
Molecular
Conventional
By Infection
UTI
Pneumonia
Surgical site infection
Blood stream infections
Others
By Product
Consumables
Instruments
By Type
Blood tests
Urinalysis